3Q24 earnings below expectations due to margin contraction
–2023 guidance cut, expecting recovery in 2024
2Q loss reduction trend better than expectation
Expect an improving trend after a weak 1Q24
We expect prudent guidance but decent margins
Operation Aspides, or the Peril of Low Expectations in Yemen
Expect steady growth with policy tailwinds
Expect strong sales in 2023 driven by the US approval of zanubrutinib in CLL
China Auto Sector – Jun leading indicators: NIO weaker than expected
Expect higher ASP following China’s stimulus